close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Jay Shah , Urologic Oncologist

LOCATION OF PRACTICE
Stanford Medicine
ABOUT

Dr. Jay Shah is a urologic oncologist specializing in the treatment of bladder cancer and other urologic cancers at the Stanford Cancer Center and is the Genitourinary Cancer Care Program Leader. He has a special interest in robotic surgery, emerging treatment options, and optimization of post-surgical recovery.

Dr. Jay Shah profile image

Published Articles

Scm3 interacts with the N-terminal tail of Cse4 to regulate kinetochore assembly in budding yeast.- 2026 May 22
Aerial drones for graft transport - ready for takeoff?- 2026
Indian Expert Consensus on Hybrid Cardiac Rehabilitation in the Management of Cardiovascular Disease.- 2026 Apr
Navigating Through Catastrophe: Successful Unsheathed Stent Extraction in Acute Myocardial Infarction.- 2026 Jun
Clostridioides difficile infection in inflammatory bowel disease: an observational study in flares of ulcerative colitis and a South Asian region-specific systematic review and meta-analysis.- 2026
Optimizing mild traumatic brain injury (mTBI) triage: A comparative analysis of CEREBO® vs clinical prediction in reducing CT utilization and improving cost-effectiveness.- 2026 May 12
Correction: Laparoscopic-total extraperitoneal anterior rectopexy (L-TEAR)-a preliminary report.- 2026 May 13
Fostering Accessibility to Mental Health Services for Youth Experiencing Homelessness in Montreal, Canada: A Historical Cohort Comparison Study.- 2026 May 13
A Global Paediatric IR Moonshot: Establishing, Improving and Maintaining Quality in Paediatric IR Globally.- 2026 May 12
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia.- 2025 Dec 5

Clinical Trials

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
CCM OPEN HF Registry
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Introduction of Microsystems in a Level 3 Neonatal Intensive Care Unit
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Mobile Health for Adherence in Breast Cancer Patients

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider